View Post

Immunotherapy for lung cancer: Researchers working to broaden its reach

In Clinical Trials by Barbara Jacoby

By: Scott Merville From: Immunotherapy drugs have produced promising results in cancers like melanoma and leukemia, yet the drugs only work for 20 percent of lung cancer patients. MD Anderson researchers are working to change that. Immunotherapy drugs that free the immune system to attack cancer have provided durable responses for about 20 percent of lung cancer patients, which …

View Post

Lilly leaps into new frontier of cancer drugs

In In The News by Barbara Jacoby

By: J.K. Wall From: The hottest trend in all of pharmaceuticals right now is to use the body’s immune system to fight cancer. But the first wave of innovation in this field skipped past Eli Lilly and Co., because the company was focused in other areas. So now the Indianapolis-based drugmaker is trying to catch what it hopes will …